Últimos artículos en español
Plataforma Chile Mejor sin TLC: “El argumento de que el TPP11 asegura crecimiento no tiene fundamento” |
TPP11 o la vuelta de espalda la soberanía nacional |
¿Vientos de cambio en los tratados de libre despojo? |
medicines
The funny thing about the free trade agreement with the United States is that Australians and Americans see it as being about completely different things. Australia’s businesspeople see it as about eliminating the barriers to exports and imports between the two countries, which they regard as a good thing.
Kerryn Williams spoke to David Henry, clinical pharmacology professor at Newcastle University and former Pharmaceutical Benefits Advisory Committee member, about how the proposed US-Australia Free Trade Agreement will undermine the Pharmaceutical Benefits Scheme, and increase the price of medicine.
Re: Excluding Intellectual Property from negotiations over
a U.S.- Southern African Customs Union (SACU) Free Trade Agreement
Developing countries have entered into a large number of bilateral investment treaties (BITs) as well as free trade agreements (FTAs) that include explicit obligations for the protection of intellectual property rights as "investments".
A long-awaited Australia-US free trade agreement (FTA) hit a new snag in Canberra, just hours after US President George W. Bush reaffirmed Washington’s commitment to a pact he called "a milestone in the history of our alliance".
Welcome to the brave new world of “Free” Trade. This is a world that extends beyond the World Trade Organisation. This may be difficult to comprehend, but the fact of the matter is that global capital, led by the US government, seeks more and more to tread where even the WTO did not.
If Howard and Bush’s so-called ’free trade’ deal is confirmed by the Australian parliament and senate (WHICH CAN ONLY HAPPEN IF THE ALP VOTES WITH THE GOVERNMENT), genetically engineered crops and foods will be forced down our throats and onto our farms, and our hopes for GE-free Australia will end!!
The government lied when it said it would exclude medicines from the list of products included under the prospective freetrade agreement between Thailand and the United States, a seminar was told yesterday.
The Medical Journal of Australia, published by the Australian Medical Association, this week carries two articles claiming the free trade agreement (FTA) will undermine the Pharmaceutical Benefits Scheme (PBS).
Bilateral trade treaties have hit stormy waters in recent weeks, drawing criticism from French President Jacques Chirac, a leading world economist and human rights groups alike.
The reason for President Museveni’s renewed vigour to support US ideologies in the battle against HIV/Aids is becoming clearer after Bangkok, Thailand.
As public-health groups urge wider use of generic drugs to lower the cost of treating AIDS and other diseases in developing countries, U.S. trade negotiators — prodded by the drug industry — are taking the opposite stance in new trade pacts, seeking to strengthen protections for costlier brand-name drugs.
The US and France clashed on Tuesday over allegations by President Jacques Chirac that Washington was seeking to use bilateral trade agreements to reduce developing countries’ access to cheap medicines for diseases such as HIV/Aids.
As the United States and Peru negotiate a bilateral trade pact, a United Nations human rights expert has urged them to ensure any agreement includes public health safeguards so that essential drugs do not become unaffordable for millions of Peruvians.
Critics voiced doubt yesterday over Prime Minister Thaksin Shinawatra’s promise to provide equitable access to life-saving drugs for all people with HIV/Aids in Thailand, saying it was a pipe dream while disputes over patented drugs remain unresolved.
Politicians from Australia’s opposition party could try to derail the Australian-US Free Trade Agreement (AUSFTA) after a Senate select committee claimed the deal could push up drugs prices and give copyright owners in Australia even more protection than they enjoy in the US.
The free trade agreement with the United States would lead to Australians paying 30 per cent more for prescription drugs, a leading American academic warned today.
The Australian Senate should delay implementing legislation for the Free Trade Agreement with the US. Countries such as Brazil and Thailand, with large generic pharmaceutical industries, are looking to Australia for leadership in countering this US bilateral push for global uniformly of high pharmaceutical prices through aggressive intellectual property (IP) protection.
Disagreements over trade in pharmaceuticals may bog down pending free trade agreements between the U.S. and foreign nations.
A free trade agreement due to be signed between Morocco and the USA by the end of this year could threaten access to medicines, several non-governmental organisations (NGOs) warned last week.
